In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

Close

logo

English
  • Svenska
  • About us
    About us
      • This is Calliditas
      • Vision and Strategy
      • Board of Directors
      • Management team
      • Corporate responsibility
      • Our history
  • Disease overview
    Disease overview
      • IgA nephropathy
      • Nefecon
      • Orphan drugs
  • Media
    Media
      • Press releases
      • Subscribe
      • Contacts
  • Contacts
    Contacts
      • Offices
      • Partnering
      • Media
      • Career
  • Svenska

Media
Mikael Widell
Mikael Widell
Head of Communications and IR
E-mail: mikael.widell@calliditas.se
Mobile: +46 703 11 99 60
  • Contacts
    • Offices
    • Partnering
    • Media
    • Career

Calliditas Therapeutics AB
Wallingatan 26B
SE-111 24 Stockholm
Sweden

Company number: 556659-9766

  • Personal data
  • About cookies

© Calliditas Therapeutics AB 2018